Kaposi Sarcoma, Susceptibility To

Description

Kaposi sarcoma (KS) is an invasive angioproliferative inflammatory condition that occurs commonly in men infected with human immunodeficiency virus (HIV; see {609423}). In the early stages of KS, lesions appear reactive and are stimulated to grow by the actions of inflammatory cytokines and growth factors. In the late stages of KS, a malignant phenotype that appears to be monoclonal can develop. Infection with human herpesvirus-8 (HHV-8), also known as KS-associated herpesvirus (KSHV), is necessary but not sufficient for KS development. Coinfection with HIV markedly increases the likelihood of KS development, and additional environmental, hormonal, and genetic cofactors likely contribute to its pathogenesis (summary by Foster et al., 2000).Suthaus et al. (2012) noted that HHV-8 is the etiologic agent not only of KS, but also of primary effusion lymphoma and plasma cell-type multicentric Castleman disease (MCD).

Genes related to Kaposi Sarcoma, Susceptibility To

Clinical Features

Top most frequent phenotypes and symptoms related to Kaposi Sarcoma, Susceptibility To

Milia
Neoplasm
Hypertension
Tics
Edema
Coma
Pneumonia
Immunodeficiency
Lymphadenopathy
Lymphoma

And another 7 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Not enough data available about incidence and published cases.

Accelerate your rare disease diagnosis with us

Learn more

Kaposi Sarcoma, Susceptibility To Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Crohn Disease. By Bioscientia GmbH Center for Human Genetics in Germany. NOD2, IL6 Specificity 50 % Genes 100 %
IL6. By Fulgent Genetics Fulgent Genetics in United States. IL6 Specificity 100 % Genes 100 %
OmniSeq Comprehensive. By OmniSeq, Inc. in United States. BRCA1, BRCA2, VHL, APC, MSH2, MLH1, PTEN, TP53, FOXL2, HNF1A, PPARG, WT1, RB1, RET, RAF1, IDH2, SOX2, STAT3, PNP, FGFR3 , (...) View the complete list with 124 more genes Panel GTR000552042 complete gene list BRCA1, BRCA2, VHL, APC, MSH2, MLH1, PTEN, TP53, FOXL2, HNF1A, PPARG, WT1, RB1, RET, RAF1, IDH2, SOX2, STAT3, PNP, FGFR3, AR, BRAF, HRAS, KRAS, MAP2K1, NRAS, PTPN11, FGFR2, MAP2K2, TSC2, CBL, TSC1, ALK, ATM, PTCH1, NF2, CDH1, STK11, CDK4, CDKN2A, MET, CHEK2, MAX, SMAD4, GATA2, PAX5, MPL, BTK, NTRK1, NF1, FGFR1, GATA3, MED12, CTNNB1, MTOR, NOTCH1, DNMT3A, EZH2, ACVRL1, TERT, NKX2-1, ERBB3, SMARCB1, KIT, JAK3, GNAS, BAP1, PIK3CA, MYCN, CSF1R, GNAQ, FLT3, NPM1, EGFR, JAK2, ABL1, U2AF1, TET2, SF3B1, PDGFRA, MYD88, IDH1, FBXW7, GNA11, AKT3, AKT1, PIK3R1, NTRK2, SRC, CDK6, KDR, CCND1, ETV5, IGF1R, MDM2, DDR2, ERBB2, SMO, MYC, BIRC3, AXL, PPP2R1A, ERBB4, RAC1, IL6, CCNE1, NFE2L2, ARAF, ROS1, MYCL, NTRK3, FGFR4, ESR1, MAPK1, CD44, IFITM3, MYO18A, CD274, ERG, PDCD1LG2, DCUN1D1, CSNK2A1, MAGOH, MCL1, BIRC2, BCL9, MDM4, ATP11B, APEX1, IFITM1, KNSTRN, JAK1, ZNF217, XPO1, TIAF1, SPOP, RHEB, RPS6KB1, GAS6, ETV1, ETV4, BCL2L1, RHOA, NKX2-8 Specificity 1 % Genes 100 %
Inflammatory Bowel Disease (IBD) and Related Disorders , Panel Massive Sequencing (NGS) 46 Genes. By Reference Laboratory Genetics in Spain. TGFB1, CYBA, IL2RG, IKBKG, TINF2, CYBB, WAS, GATA3, FOXP1, FOXP3, DKC1, ABCB1, TERC, TERT, SH2D1A, NCF2, NCF4, WRAP53, NOD2, CD40LG , (...) View the complete list with 25 more genes Panel GTR000559806 complete gene list TGFB1, CYBA, IL2RG, IKBKG, TINF2, CYBB, WAS, GATA3, FOXP1, FOXP3, DKC1, ABCB1, TERC, TERT, SH2D1A, NCF2, NCF4, WRAP53, NOD2, CD40LG, XIAP, STXBP2, WIPF1, CTLA4, IL10RA, IL17F, CARD9, ICOS, IL10RB, IL2RA, IL10, PLCG2, NCF1, MYO5B, GUCY2C, IL21, IL21R, IL17RA, IL6, ADAM17, ATG16L1, FUT2, IL23R, IRGM, PTGER4 Specificity 3 % Genes 100 %

Alternate names

Kaposi Sarcoma, Susceptibility To Is also known as multiple idiopathic pigmented hemangiosarcoma, susceptibility to.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA